News

AbCellera Biologics stock has surged year to date, yet the company scores poorly on broad valuation checks and currently screens as expensive on market multiples. After a strong run supported by positive clinical news, investors are weighing whether the recent share price strength already reflects much of the good news. Year to date, AbCellera Biologics has delivered a very large 172.3% return, which puts extra focus on whether the current price offers enough margin for error. The recent...

The reusable orbital rocket maker still looks pricey relative to its growth potential.

Klarna Group (NYSE:KLAR) is providing the leasing and financing backbone for Apple's new Apple Upgrade program in the United States. The partnership integrates Klarna into one of Apple's core hardware ownership offerings, expanding Klarna's exposure to US Apple customers. The role places Klarna more directly in consumer electronics financing beyond its existing buy now, pay later services. This kind of tie up is only one way to gain exposure to stable consumer themes. It can be useful to...

Investing.com -- S&P 500 companies are on course for 32% year-on-year EPS growth in the second quarter of 2026, following a 30% jump in Q1. This back-to-back earnings run rivals the strongest on record.

Teradyne (TER) has arranged a new five year senior secured revolving credit facility of up to US$1.0b, giving the company additional funding flexibility for working capital and general corporate purposes without currently drawing on it. See our latest analysis for Teradyne. Teradyne’s share price has seen short term pressure, with a 1 day share price return that declined 3.75%. However, momentum over the year remains strong, highlighted by a year to date share price return of 75.90% and a...

Babcock & Wilcox (NYSE:BW) shares surged 40. 5% to $12.

Nvidia (NASDAQ:NVDA) has unveiled a strategic partnership with six major financial groups aimed at mobilising more than $500 billion in third-party capital to finance the continued expansion of artificial intelligence infrastructure. The initiative brings Nvidia together with Apollo (NYSE:APO), BlackRock (NYSE:BLK), Blackstone (NYSE:BX), Brookfield (NYSE:BAM), Goldman Sachs (NYSE:GS) and KKR (NYSE:KKR) to establish independent computing financing platforms.

Intel (NASDAQ:INTC) raised $20 billion through an expanded share offering on Tuesday, taking advantage of the sharp rally in its stock to secure additional funding for its capital-intensive push into contract chip manufacturing. The chipmaker priced the offering at $95 per share, representing a 2.

Energy Transfer is rapidly becoming one of the most dependable dividend growers in the midstream space, and that's saying something.

Rocket Lab (NASDAQ:RKLB) shares came under pressure after the space technology company reported quarterly results that highlighted strong revenue growth but disappointed Wall Street on earnings and its profitability outlook. The company posted a loss of $0.

Plus, a Tesla-SpaceX merger gives Elon Musk a shortcut to his $1 trillion payday, and the University of Michigan drops first-semester grades to “curb a mental health crisis.”

Ahead of Cisco Systems, Inc‘s fourth-quarter earnings report on Wednesday, Aug. 12, investors may be eyeing potential gains from the company’s dividends. Currently, Cisco has an annual dividend yield of 1.38%, which is a quarterly dividend amount of 42 cents...

Buying Varex will increase Teledyne’s exposure to the healthcare market. Teledyne said the companies’ imaging technologies complement each other with minimal overlap.

The Trump administration's investments in corporate stocks make it a significant shareholder in an unprecedented 30 companies. Voters and economists are uneasy.

Intel said Monday it plans to raise $15 billion by selling new shares to investors, giving it fresh cash for factories, equipment, day-to-day operations, and other needs. That comes with a cost for existing shareholders — one that its recent stock rally has dramatically reduced.

BlackRock's head of digital assets, Robert Mitchnick, appeared for an interview on Bloomberg on Aug. 10 in which he shared strong words on the sentiment prevalent among Bitcoin investors right now. BlackRock launched iShares Bitcoin Trust (IBIT), its spot Bitcoin exchange-traded fund ...

Futures, perpetuals and options spanning crypto, commodities, equities and FX, limited to clients who qualify as professional investors.

Companies In The Article Are:BA,INTC,HZO,ABCL and ACHR

UnitedHealth Group has outpaced the broader market over the past year, and analysts remain highly bullish about the stock’s prospects.

Wall Street closed lower on Monday as higher oil prices fueled concerns over inflation and interest rates

This trio of Dow giants could be worth a closer look this August.

Taiwan ‌chipmaker TSMC ​said on Tuesday it ‌will ⁠invest 282 billion ⁠yen ($1.77 billion) ​in ​a ​joint ‌venture with Sony Group to ‌develop ​and ​make ​next-generation ‌image sensors. ($1 = 159.3300 ​yen) (Reporting ​by ​Ben Blanchard; ‌Editing ​by Andrew ​Heavens)

Most ordinary people's investment wealth is built just a few dollars at a time. The key is committing to the process for years on end.

Investing.com -- On Holding shares fell sharply after the Swiss sportswear maker’s second-quarter revenue fell short of expectations.

Micron Technology, Inc. (NASDAQ:MU) stock gained over a percent during Tuesday’s premarket session as risk appetite stays steady into the open. Nasdaq futures are up less than half a percent while S&P 500 futures have gained 0.02%.The company executives said at the KeyBanc Capital Markets Technology Leadership Forum 2026 on Aug. 10 that AI is reshaping memory demand, tightening supply and making long-term customer agreements a bigger part of the company’s growth strategy.AI Demand Drives Memory

Atlassian looks so good that the company is buying back $250 million worth of stock.

Biopharmaceutical drug delivery company Halozyme Therapeutics (NASDAQ:HALO) announced better-than-expected revenue in Q2 CY2026, with sales up 47.7% year on year to $481 million. The company’s full-year revenue guidance of $1.87 billion at the midpoint came in 5.9% above analysts’ estimates. Its non-GAAP profit of $2.28 per share was 25.5% above analysts’ consensus estimates.

The first phase of Terafab costs more than four times what the electric-car maker earned over the past year.

For years, healthcare and semiconductor stocks weren’t particularly tied to each other. In other words, they increasingly go in opposite directions: when chips sell off, healthcare has tended to catch a bid. After years of underperformance, healthcare investors are enjoying a burst of momentum amid the recent nervousness around AI.

This Steady Eddie compounder is down 45% from its 52-week high, and its president and CEO is buying shares.